Irritant contact dermatitis from exposure to povidone-iodine may resemble toxic epidermal necrolysis. 2006

Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.

UI MeSH Term Description Entries
D011206 Povidone-Iodine An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes. PVP-Iodine,Polyvinylpyrrolidone Iodine,Alphadine,Betadine,Betaisodona,Disadine,Isodine,PVP-I,Pharmadine,Providine,Alphadines,Betadines,Disadines,Isodines,PVP Iodine,PVP-Iodines,Pharmadines,Polyvinylpyrrolidone Iodines,Povidone Iodine,Povidone-Iodines,Providines
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000891 Anti-Infective Agents, Local Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. Anti-Infective Agents, Topical,Antiseptic,Antiseptics,Microbicides, Local,Microbicides, Topical,Antiinfective Agents, Local,Antiinfective Agents, Topical,Local Anti-Infective Agents,Local Antiinfective Agents,Topical Anti-Infective Agents,Topical Antiinfective Agents,Agents, Local Anti-Infective,Agents, Local Antiinfective,Agents, Topical Anti-Infective,Agents, Topical Antiinfective,Anti Infective Agents, Local,Anti Infective Agents, Topical,Local Anti Infective Agents,Local Microbicides,Topical Anti Infective Agents,Topical Microbicides
D013262 Stevens-Johnson Syndrome Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis. Drug-Induced Stevens Johnson Syndrome,Drug-Induced Stevens-Johnson Syndrome,Epidermal Necrolysis, Toxic,Lyell's Syndrome,Mycoplasma-Induced Stevens Johnson Syndrome,Mycoplasma-Induced Stevens-Johnson Syndrome,Nonstaphylococcal Scalded Skin Syndrome,Scalded Skin Syndrome, Nonstaphylococcal,Stevens Johnson Syndrome Toxic Epidermal Necrolysis,Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,Toxic Epidermal Necrolysis,Toxic Epidermal Necrolysis Stevens Johnson Syndrome,Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum,Toxic Epidermal Necrolysis Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum,Drug Induced Stevens Johnson Syndrome,Drug-Induced Stevens-Johnson Syndromes,Epidermal Necrolyses, Toxic,Lyell Syndrome,Lyell's Syndromes,Mycoplasma Induced Stevens Johnson Syndrome,Necrolyses, Toxic Epidermal,Necrolysis, Toxic Epidermal,Stevens Johnson Syndrome,Stevens-Johnson Syndrome, Drug-Induced,Stevens-Johnson Syndrome, Mycoplasma-Induced,Stevens-Johnson Syndromes, Drug-Induced,Syndrome, Lyell's,Syndrome, Mycoplasma-Induced Stevens-Johnson,Syndromes, Lyell's,Toxic Epidermal Necrolyses
D017453 Dermatitis, Irritant A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms. Dermatitis, Primary Irritant,Irritant Dermatitis,Dermatitides, Irritant,Dermatitides, Primary Irritant,Irritant Dermatitides,Irritant Dermatitides, Primary,Irritant Dermatitis, Primary,Primary Irritant Dermatitides,Primary Irritant Dermatitis

Related Publications

Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
May 1989, Journal of the American Academy of Dermatology,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
November 2022, BMJ case reports,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
January 2003, Journal of investigational allergology & clinical immunology,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
February 2010, Indian journal of pharmacology,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
August 2009, Indian journal of pharmacology,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
March 2021, Ear, nose, & throat journal,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
August 1985, Contact dermatitis,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
June 1999, Contact dermatitis,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
April 1982, Journal of the American Academy of Dermatology,
Travis W Vandergriff, and Carina A Wasko, and Mary R Schwartz, and Sylvia Hsu
June 2009, Contact dermatitis,
Copied contents to your clipboard!